ID
23501
Beschrijving
A Study of Avastin (Bevacizumab) and Sequential Chemotherapy in Patients With Primary HER2 Negative Operable Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00559754
Link
https://clinicaltrials.gov/show/NCT00559754
Trefwoorden
Versies (1)
- 08-07-17 08-07-17 -
Geüploaded op
8 juli 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00559754
Eligibility Breast Cancer NCT00559754
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Prior Therapy Breast Carcinoma
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C0678222
Beschrijving
Neoplasm Metastasis
Datatype
boolean
Alias
- UMLS CUI [1]
- C0027627
Beschrijving
Aspirin U/day | Avastin | Anticoagulants Dose Full
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0004057
- UMLS CUI [1,2]
- C0456683
- UMLS CUI [2]
- C1135130
- UMLS CUI [3,1]
- C0003280
- UMLS CUI [3,2]
- C0178602
- UMLS CUI [3,3]
- C0443225
Beschrijving
Cardiovascular Diseases
Datatype
boolean
Alias
- UMLS CUI [1]
- C0007222
Similar models
Eligibility Breast Cancer NCT00559754
- StudyEvent: Eligibility
C0001779 (UMLS CUI [2])
C0205225 (UMLS CUI [1,2])
C4087376 (UMLS CUI [1,3])
C0205188 (UMLS CUI [1,4])
C0678222 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,2])
C1135130 (UMLS CUI [2])
C0003280 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0443225 (UMLS CUI [3,3])